tiprankstipranks
Trending News
More News >

OncoSil Medical Ltd Updates Securities Issuance Plan

Story Highlights
  • OncoSil Medical Ltd updates its securities issuance under a Securities Purchase Plan.
  • The update includes a 1 for 400 share consolidation and final issue price announcement.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
OncoSil Medical Ltd Updates Securities Issuance Plan

Don’t Miss TipRanks’ Half-Year Sale

An announcement from OncoSil Medical Ltd ( (AU:OSL) ) is now available.

OncoSil Medical Ltd announced an update regarding the issuance of securities under a Securities Purchase Plan (SPP), which was approved by shareholders during an Extraordinary General Meeting (EGM) held on July 8, 2025. This update includes an amendment to the number of shares and options, reflecting a 1 for 400 consolidation approved earlier on May 29, 2025, and the final SPP issue price announced on July 7, 2025. This move is part of the company’s strategic financial adjustments, potentially impacting its market positioning and shareholder value.

More about OncoSil Medical Ltd

OncoSil Medical Ltd operates in the medical industry, focusing on developing and commercializing innovative medical devices. The company’s primary product is a targeted radioactive isotope treatment for pancreatic and liver cancer, aiming to improve patient outcomes through advanced therapeutic solutions.

Average Trading Volume: 42,531

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$16.71M

Learn more about OSL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1